Gene: ACSL5
Official Full Name: acyl-CoA synthetase long chain family member 5provided by HGNC
Gene Summary: The protein encoded by this gene is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme is highly expressed in uterus and spleen, and in trace amounts in normal brain, but has markedly increased levels in malignant gliomas. This gene functions in mediating fatty acid-induced glioma cell growth. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22263 | ACSL5 Knockout cell line (HeLa) | Human | ACSL5 | 1:3~1:6 | Negative | Online Inquiry |
KO22264 | ACSL5 Knockout cell line (HCT 116) | Human | ACSL5 | 1:2~1:4 | Negative | Online Inquiry |
ACSL5 Gene Knockout Cell Lines are specialized cell lines that have undergone targeted gene editing to inactivate the Acyl-CoA Synthetase Long-Chain Family Member 5 (ACSL5) gene. These knockout models are essential research tools for investigating the role of ACSL5 in fatty acid metabolism, cell signaling, and various metabolic diseases, including obesity and type 2 diabetes.
The fundamental mechanism of these cell lines involves the disruption of the ACSL5 gene, which encodes an enzyme critical for the conversion of long-chain fatty acids to their CoA derivatives. By studying these knockout lines, researchers can elucidate the enzyme's role in lipid metabolism, energy homeostasis, and its implications in pathological conditions. The lack of functional ACSL5 provides an invaluable opportunity to explore compensatory pathways and metabolic adaptations within the cell, granting insights into potential therapeutic targets.
ACSL5 Gene Knockout Cell Lines hold significant scientific importance in both academic and clinical research settings. Their applications span from fundamental studies of lipid biochemistry to drug discovery and the development of metabolic disorder treatments. Utilizing these cell lines allows researchers to better understand the contributions of ACSL5 to various physiological and pathological processes, facilitating advancements in precision medicine.
Compared to conventional cell lines, our ACSL5 knockout models offer highly reproducible results and a more profound understanding of gene function in specific metabolic contexts. The specificity of gene targeting ensures minimal off-target effects, providing confidence in experimental outcomes. This precision makes our cell lines superior alternatives to less specific methodologies, such as pharmacological inhibition or RNA interference.
For researchers and clinicians focused on metabolic research and therapeutic development, ACSL5 Gene Knockout Cell Lines represent a powerful asset that can lead to innovative discoveries and treatments. Our company boasts extensive expertise in the field of genetic engineering and cellular models, ensuring that our products are of the highest quality and reliability, tailored to meet the needs of modern research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.